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Abstract: Acinetobacter baumannii is a typically short, almost round, rod-shaped (coccobacillus)
Gram-negative bacterium. It can be an opportunistic pathogen in humans, affecting people with
compromised immune systems, and it is becoming increasingly important as a hospital-associated
(nosocomial) infection. It has also been isolated from environmental soil and water samples. In this
work, unlike conventional medical methods like antibiotics, the influence of atmospheric-pressure
cold plasma on this bacterium is evaluated by means of a colony count technique and scanning
electron microscopy. The plasma used here refers to streamers axially propagating into a helium
channel penetrating the atmospheric air. The plasma is probed with high resolution optical
emission spectroscopy and copious reactive species are unveiled under low-temperature conditions.
Based on the experimental results, post-treatment (delayed) biochemical effects on Acinetobacter
baumannii and morphological modifications appear dominant, leading to complete deactivation of
this bacterium.
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1. Introduction
Atmospheric-pressure plasma jets (APPJs) are novel micro-discharges, which allow for the
effective formation of user-friendly non-thermal plasmas under ambient-air conditions. They are
mainly produced by means of Dielectric-Barrier Discharge (DBD) reactors of different electrode
configurations and dielectric materials [1]. These devices are electrically driven mostly by sinusoidal
and pulsed high voltage power supplies of audio frequencies [1,2]. The use of the dielectric barrier
placed between the electrodes and the short duration of the applied voltage (in the case of pulsed power
supply) limit the discharge current. The transition to arc is thus avoided [1]. In general, the plasma is
formed in noble gases, like He or Ar [1,2], due to their higher ionization efficiency with respect to that
of the ambient air under the same reduced electric field [2,3]. The discharge comprises a DBD region,
a displacement along the dielectric tube and a penetration into the atmospheric air at distances up to a
few centimeters [4–6].
Although APPJs appear as continuous bright “plumes” to the naked eye, in fact they consist of
ultrafast discrete ionization fronts widely known as “plasma bullets” [3,7,8] and, more recently,
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as “guided streamers” [2–4,9]. The latter term mirrors better the physical nature of APPJs.
The streamers propagate inside the thin noble gas channel (few millimeters or lower in diameter)
with velocities in the order of tens of km s−1 [1–4,10–12], which are two-three orders of magnitude
higher than that of the noble gas itself [4]. This means that the plasma formation outside the reactor is
an electrically-driven phenomenon, which is strongly coupled with the noble gas dynamics and its
mixing with the ambient air [13–15].
During the last fifteen years, numerous works have been devoted to the development and
systematic characterization of APPJs, not only for fundamental research purposes [2–5,16–18],
but also for their implementation in novel technological domains (material-surface processing [19–22],
food industry and agriculture [23], and biomedicine [24–31]). These applications are promoted due
to APPJ special features, like relative low construction cost, portability, µm-to cm-scale application,
low temperature of the gaseous medium (even near to the room one for well-defined operational
windows [5,32]), and mostly due to their operation at atmospheric air which permits the effective
production of various (re)active species.
These species refer to excited neutrals (atoms/molecules) including long-living metastables,
ground state reactive radicals, electrons over a wide range of energy (from eV to tens of eV),
atomic/molecular ions, photons (UVA, UVB, UVC, visible) etc., combined with electromagnetic
and gas flow fields. Specifically, in the plasma biomedicine area, the synergetic action of the
above plasma-induced components is responsible for the effects observed on discrete living samples.
Especially, the so-called Reactive Oxygen and Nitrogen Species (RONS) [33] play a crucial role
in wound healing and tissue regeneration, blood coagulation, sterilization, decontamination,
plasma-mediated cancer therapy and killing of micro-organisms. Besides, metastable states [16,34]
act as energy reservoirs by stocking energy for relatively long time, supporting thus excitation and
ionization processes outside the reactor where biological specimens are being placed. APPJ potential
reactivity is discussed below in more detail.
Among other topical applications of APPJs in biomedicine, particularly interesting (and
increasingly studied) are their interactions with micro-organisms. Nosocomial or health-care associated
infections, including bacteremia, represent a leading cause of death worldwide [35]. Most importantly,
the irrational and excessive consumption of antimicrobial agents has led to multi- or even pan-drug
resistant bacterial strains, leaving no available treating options in the armamentarium of clinicians.
Looking to the twilight of the era of antibiotics, other treatment approaches appear thus as an appealing
as well as an imperative alternative.
Towards this direction, the efficiency of APPJs to the inactivation of different kinds of
bacteria and fungi has been tested widely. Interrogated microorganisms in different reports are
given below, just to mention a few: Escherichia coli, Staphylococcus aureus and Pseudomonas
aeruginosa [36], Escherichia coli, Bacillus subtilis and Pseudomonas aeruginosa [37], Escherichia
coli, Bacillus atrophaeus and Staphylococcus aureus [38], Escherichia coli [39], “skin flora” (mix
of bacteria) [40], Escherichia coli [41], Escherichia coli and the derived lipopolysaccharide [42],
Enterococcus faecalis and Staphylococcus aureus [43], Escherichia coli and methicillin-resistant
Staphylococcus aureus [44], Staphylococcus aureus [45], Candida biofilms [46], Bacillus subtilis
spores [47], bacteria of skin samples consisting of Staphylococci, Streptococci and Candida species
of yeast [48,49], Escherichia coli [50], methicillin-resistant Staphylococcus aureus, Pseudomonas
aeruginosa and Candida albicans [51], biofilms produced by Escherichia coli, Staphylococcus
epidermidis and methicillin-resistant Staphylococcus aureus [52], Escherichia coli, Staphylococcus
aureus, Micrococcus luteus, Bacillus natto, Bacillus subtilis and Bacillus megaterium [53], Bacillus
stearothermophilus spores [54], Bacillus globiggi [55], Bacillus subtilis and Eschelichia coli [56],
Streptococcus mutans and Lactobacillus acidophilus [57], Escherichia coli and Enterococcus
mundtii and Candida albicans [58], Escherichia coli and Bacillus subtilis [59], Geobacillus
stearothermophilus [60], Bacillus atrophaeus, Geobacillus stearothermophilus, Salmonella enteritidis,
Staphylococcus aureus, Candida albicans and Aspergillus niger [61], Escherichia coli [62], Escherichia
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coli and Staphylococcus [63], Staphylococcus aureus [64], Bacillus spores [65], Pseudomonas
aeruginosa biofilms [66], Acinetobacter baumannii, Enterobacter cloacae and Staphylococcus
aureus [67], Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, Candida
kefyr [68], Escherichia coli, Staphylococcus aureus, Acinetobacter baumannii and Staphylococcus
epidermidis [69], Acinetobacter baumannii (A. baumannii) [70] etc.
In particular, A. baumannii is an aerobic Gram-negative coccobacillus that causes nosocomial
human infections, particularly in immune-compromised individuals. These infections can result
in septicemia, meningitis, endocarditis, pneumonia, wound infection, and urinary tract infections.
A. baumannii can colonize and survive for long periods of time on dry inanimate surfaces, such as
hospital equipment. In addition to its intrinsic resistance to antibiotics and desiccation, A. baumannii is
very prone to accumulating resistance mechanisms, especially in environments where antibiotic
overconsumption is taking place [71]. Its interaction with APPs has attracted interest [67–70],
since APPs could assist with the elimination of nosocomial infections associated with this bacterium,
but still not many works on this topic can be found in the literature. Parkey et al. [67] used a
single outer electrode plasma-jet reactor, Kolb et al. [68] a DC-biased micro-hollow cathode geometry,
Ercan et al. [69] a floating-electrode DBD, and Ruan et al. [70] a multi-needle DC-driven plasma source.
Thus, the reports on A. baumannii deactivation by APPJs are few and far between.
Unlike to the abovementioned excellent works, herein a coaxial DBD-based helium plasma
micro-jet is evaluated against A. baumannii deactivation. This setup has been previously used for
liposome [29,30] and human skin [31] treatment, under various conditions. Thus, here colony counting
and scanning electron microscopy (SEM) provide insights into the plasma-induced damage of A.
baumannii and it is shown that post-treatment (delayed) effects are dominant. Bacterial population is
extensively diminished (reduction of seven orders of magnitude, without the need for co-injected air as
in reference [67]) and remaining bacteria resemble ghost bacteria consisting of ruptured and destroyed
cell membrane. Possible decontamination mechanisms, based on optical emission spectroscopy (OES)
results of the present study and bibliography, are discussed.
2. Experimental Setup and Specimens
2.1. Plasma Setup
The specifications of the plasma-jet reactor employed here for the bacterium treatment and the
involved physics for the same [29–31] or similar [4,5,12,32,72,73] coaxial DBD-based systems have
been discussed in these previous reports of our group. The present operational window (see below) is
selected as an effective one, based on those previous studies. Additionally, although we are aware that
any aqueous solution may alter the plasma-jet features, acting practically as a third (liquid) electrode,
we provide here conventional results from the free running plasma-jet case as indicative ones, whereas
we focus our attention on the possibility of A. baumannii deactivation. The role of the bacterial
suspension in the plasma features is a part of our ongoing research.
Briefly, as in Figure 1, a thin tungsten wire (diam. 0.125 mm) is inserted in an alumina capillary
tube (inner diam. 1.14 mm). A brass hollow cylinder (length of 10 mm) is attached on the outer surface
of the alumina in such a way to be extended up to the tip of the wire. The distance between the tip of
the wire and the tube orifice is 20 mm. Helium gas (N50) is introduced in the tube with a controllable
flow rate. The wire is biased by a laboratory-built high voltage power supply (10 kHz sinusoidal;
0–12 kV peak-to-peak) and the cylinder is grounded directly. By this configuration, radial DBDs
are developed and axial “guided streamers” propagate [12,73] in the atmospheric air where helium
diffuses. Here, the voltage and the flow are fixed at 11.5 kV and 2 slm, respectively, and a plasma
“plume” of about 35 mm is achieved. Figure 2 presents a typical pair of the driving voltage and
the generated DBD current waveforms, as they are recorded by means of a wideband high voltage
divider (Tektronix P6015; DC–75 MHz, Beaverton, OR, USA) and wideband current monitor (Pearson
Electronics 6585; 40 Hz–200 MHz, Palo Alto, CA, USA), respectively, on a digital oscilloscope (LeCroy
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WaveRunner 44Xi-A; 400 MHz; 5 GSamples s−1, Chestnut Ridge, NY, USA). Emissive species and gas
temperature are identified by UV-visible, high resolution OES, as described in references [4,29–32].
In particular, the gas temperature is evaluated by comparing experimentally-determined rotational
distributions of probe molecules with the corresponding theoretical ones calculated with a software
developed previously [74]. The probed zone is 20 mm along the plasma-jet axis with respect to the
tube orifice.
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2.2. Bacteria Preparation and Treatment
The bacterium under study is A. baumannii. All strains are isolated in the Department of Clinical
Microbiology, University Hospital of Patras, Greece, from the blood of patients treated for bloodstream
infections and represent multi-resistant strains. All microbial strains used in this study are stored in
TSB (Tryptic Soy Broth; BBL, Microbiology, Cockeysville, MD, USA) supplemented with 20% glycerol at
−70 ◦C and, when needed, they are sub-cultured on blood agar plates (BioMérieux S.A., Marcy-l’Étoile,
France) for 24 h at 37 ◦C.
Each bacterial isolate is suspended in PBS (Phosphate-Buffered Saline; pH 7.2) and photo-
metrically adjusted to the desired concentration of 3 × 106 CFUs mL−1 (Colony Forming Units
mL−1). 1 mL from the suspension is added in each of nine (three for each treatment time) wells of
a 24-well flat bottom tissue culture plate (Sarstedt, Newton, USA). Bacterial suspensions are treated
at 4 mm distance between the tube orifice and the surface of the aqueous solution for 0 (control
samples), 10 and 20 min. The content of each of the nine wells is kept at 4 ◦C in separate sterile
EppendorfTM tubes.
Different dilutions of each suspension are sub-cultured at 2, 6, 24, 48 and 72 h upon plasma
treatment on blood agar plates and incubated for 24 h at 37 ◦C. Corresponding bacterial concentration
is thus estimated. The effect of the plasma treatment is evaluated depending on the number of live
bacteria capable of forming colonies on solid media. Bacterial concentration at the content of the three
wells that are not treated with plasma (0 min) is used as control reference. The effect of helium gas
itself (plasma off) on the bacterial viability is evaluated by subjecting bacterial suspensions to 2 slm He
flow. Negligible effect is measured with respect to control samples.
2.3. Growth Inhibition Zone Experiments
For growth inhibition zone determination, an overnight culture of bacteria is diluted in PBS at a
concentration of 3× 107 CFUs mL−1 and 10 µL of the diluted bacterial suspension is then spread evenly
on the surface of 7 mm MHA (Mueller Hinton Agar) plate. The plates are exposed (in duplicate) to the
plasma for 30, 60, 120 and 240 s at distances of 10 and 15 mm from the reactor orifice. After exposure
to the plasma, the plates are incubated at 37 ◦C for 24 h in a static incubator and the diameter of the
bacterial growth inhibition zone on the agar surface is determined [75]. Since the inhibition zone
circumference is irregular, the inhibition zone diameter is approximated by applying simple image
processing techniques, i.e., zone edge detection with a Sobel-Feldman operator and optimum circular
fit, using MatlabTM.
2.4. Scanning Electron Microscopy of Bacteria
The specimens are prepared for morphological examination by Scanning Electron Microscopy
(SEM). The microscope is a LEO-ZEISS Supra 35VP instrument equipped with an Energy-Dispersive
X-ray (EDX) microanalysis unit (Bruker), allowing for elemental semiquantitative analysis of the
specimens. The content of each well is filtered on 0.45 µm filters (Sartorius, Göttingen, Germany).
Withheld bacteria on the filter surface are fixed in a solution of 2.5% glutaraldehyde overnight at
4 ◦C, carefully washed two times for 10 min in PBS and dehydrated sequentially in 10%, 30%, 50%,
70%, 80% and 90% ethanol solutions for 10 min each and eventually in ethanol 100% for 2 × 10 min,
as previously described [46,76] but with small alterations. Eventually, a thin film of about 4 nm of gold
is coated on the filter-bacteria by means of a BAL-TEC SCD-005 sputter coater.
3. Results and Discussion
Figure 3 presents the number of survived bacteria in CFUs as a function of the time elapsed upon
the termination of 10 and 20 min treatment (i.e., post-treatment). The evolution of the untreated sample
(control) is shown as well for comparison reasons. As is mentioned in Section 2.2, for each treatment
time three wells with bacterial suspension are considered, increasing thus the consistency of the results
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(i.e., CFU average is taken into account). On the top of that, as shown in Figure 3, two independent
(carried out on different dates) series of experiments under identical conditions (see Section 2.2) are
carried out, giving to the reader evidence for the standard deviation of the treatment efficiency. Clearly,
the present plasma jet has a profound effect on the A. baumannii population which is drastically
decreased mainly in the post-treatment time. The first measurement (“zero-time” point) is carried out
2 h after the treatment termination due to sample transfer and analysis waits. This first point (Figure 3)
indicates colony diminution up to four orders of magnitude. The effect is more pronounced upon
increasing bacteria exposure time to plasma. Cell death could thus be achieved either by increasing the
plasma exposure dose or by allowing adequate time for the reactive species to initiate an intracellular
signaling response in the cells [77].
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Figure 3. Post-treatment evolution of the A. baumannii formed colonies with the plasma treatment time
as parameter. Each experimental point is derived by averaging the survivors from three different wells
(see Section 2.2.), whereas open and closed symbols refer to two independent series of experiments
realized under identical conditions, hence providing a picture for the standard deviation of the results.
Figure 4 depicts the evolution of the inhibition zone on MHA versus the treatment time, as it
is observed 24 h after the treatment termination. An almost linear increase between the inhibition
zone diameter and the treatment time is obtained (Figure 5). At the same time, in Figure 5 it is seen
that as the plasma jet approaches the bacterial load, a wider inhibition zone is achieved. Although
these experiments are not designed to provide quantitative results in terms of bacterium deactivation,
an important conclusion may be extracted. The cross section of the observed plasma channel lies
approximately up to 3 mm2, whereas its visible spot at the point of contact with the specimen may be
roughly 7–9 times wider in mm2 (see e.g., Figure 1 in Ref. [31]). At the same time, the inhibition zone
covers an area up to about 250 mm2 (10 mm distance; 4 min treatment). Thus, the coverage area of the
plasma-induced active species is much broader than the plasma visible spot and may be tuned by the
working distance and the treatment time.
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Untreated and plasma-treated bacteria as probed by SEM are shown in Figure 6. Treated bacteria
are significantly fewer and are completely deformed. More specifically, they show ruptured and
shrunk morphology. It cannot be stated whether this morphological degradation is the cause or the
result of the bacteria death. In any case the plasma jet leads to leakage of intracellular ingredients
leaving empty cell walls and membranes. No correlative evidence has been observed [51] suggesting
that plasma induced widespread genomic damage or oxidative protein modification prior to the onset
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Figure 6. SEM micro-images of A. baumannii bacteria (a) untreated-control and (b). plasma-treated
for 20 min. Images were taken about 24 h after the treatment of the samples (refer to Figure 3). Both
control and treated samples were stored at 4 ◦C. (c,d) Corresponding zoomed-in micro-images (control
and treated, respectively).
According to the wide scan optical emission spectrum of the present plasma jet under the
same operating conditions (as it is analyzed elsewhere [29,30]), the aqueous solution with the
bacteria is subjected to a flow of (re)active species including: N2(C3Πu–B3Πg), N2+(B2Σ+u–X2Σ+u),
OH(A2Σ+–X2Π), He(31P–21S; 33D–23P; 31D–21P; 33S–23P), and NOβ(B2Π–X2Π) of much weaker
intensity. At the same time, the gas temperature of the free-running plasma-jet is evaluated based
on the rotational distributions of typical probe molecules (Figure 7). The measured temperature lies
between 54 and 65 ◦C. When higher resolution spectra are recorded [30], a temperature around 36 ◦C
is found. Thus, the role of heating in A. baumannii inactivation with the present setup should not be
considered the principal role, in agreement with other reports [64,65].
Plasma 2019, 2 85
Plasma 2019, 2, x FOR PEER REVIEW  9 of 14 
 
 
Figure 7. Theoretical rotational distributions fitted on experimentally determined ones for the 
estimation of the gas temperature (the residuals of the fitting procedure are also plotted). The probe 
molecules and the corresponding transitions are given in the insets. 
It is widely accepted that one single agent cannot be assigned to the plasma sterilization of 
bacteria. It is suggested that several germicidal species that include RONS [33,64,65], charged 
particles [48,64], UV radiation [47], ozone molecules [37], metastables [78] and electric field [16] may 
have a potential role. Together, they lead, possibly in combination, to inactivation of bacteria [63]. 
Furthermore, different sterilizing mechanisms proceed at different timescales. This assumption is 
supported by various published survival curves [79]. These curves describe the dependence of the 
number of surviving bacteria on the treatment time. Many of these curves exhibit a double- or multi-
slope shape, like in our case (Figure 3). Such a behavior is indicative of the relevance of several distinct 
sterilization mechanisms [63]. Bactericidical action of plasmas may be associated with (i) wall 
permeabilization by electromechanical and chemical processes (including electrostatic disruption of 
Gram-negative bacteria [80] like A. baumannii), (ii) cell penetration of reactive oxygen and nitrogen 
species and (iii) chemical reactions inside the cell that can lead to bacterial DNA destruction [81]. 
On the other hand, the above mechanisms may be direct on the bacteria or indirect by altering 
the chemical properties of the aqueous solution where the bacteria are suspended. For instance, ozone 
decomposition in water is complex and many transient oxidizing species (OH, HO2, O−, O3−, O and 
singlet 1O2) can be formed [82]. We have recently shown the formation of reactive nitrogen species 
including peroxynitrite in a physiological buffer exposed to He APPJ [28]. Girard et al. [27], using a 
micro-plasma jet produced in helium, demonstrated that the concentration of H2O2, NO2− and NO3− 
can fully account for the majority of RONS produced in plasma-activated buffer, leading finally to 
tumor cell death. Ercan et al. [69] used floating-electrode DBD and they stated that nonthermal 
plasma-treated fluids retain their antimicrobial effects for longer periods (three months by delay time 
and two years by solution aging) than was earlier thought. This fluid-mediated plasma-based 
treatment is faster than reported previously (<15 min holding time, defined as the time that plasma-
treated liquid comes in contact with the bacterial suspension) and inactivates a wide range of 
multidrug-resistant bacteria and fungal pathogens, in both their planktonic and biofilm forms. The 
antimicrobial effect is due not only to a change in pH and in the H2O2 or nitric acid but also to the 
Figure 7. Theoretical rotational distributions fitted on experimentally determined ones for the
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It is widely accepted that one single agent cannot be assigned to the plasma sterilization of bacteria.
It is suggested that several germicidal species that include RONS [33,64,65], charged particles [48,64],
UV radiation [47], ozone molecules [37], metastables [78] and electric field [16] may have a potential
role. Together, they lead, possibly in combination, to inactivation of bacteria [63]. Furthermore,
different sterilizing mechanisms proceed at different timescales. This assumption is supported by
various published survival curves [79]. These curves describe the dependence of the number of
surviving bacteria on the treatment time. Many of these curves exhibit a double- or multi-slope shape,
like in our case (Figure 3). Such a behavior is indicative of the relevance of several distinct sterilization
mechanisms [63]. Bactericidical action of plasmas may be associated with (i) wall permeabilization
by electromecha ical and chemical processes (including electrostatic isruption of Gram-negative
bacteria [80] like A. baumannii), (ii) cell penetration of reactive oxygen and nitrogen species and (iii)
chemical reactions inside the cell that can lead to bacterial DNA destruction [81].
On the other hand, the above mechanisms may be direct on the bacteria or indirect by altering
the chemical r erties f the aqueous solution where the bacteria are suspended. For instance,
ozone decomposition in water is complex and many tra sient oxidizing species (OH, H 2, −, 3−,
O and singlet 1O2) can be formed [82]. We have recently shown the f rmation of reactive nitrogen
species i cluding peroxynitrite in a physiological buffer exposed to He APPJ [28]. Girard et al. [27],
using a micro-plasma jet produced in helium, demonstrated t at the co centration of H2O2, NO2− and
NO3− can fully account for the majority of RONS produced in plasma-activated buffer, leading finally
to tumor cell death. Ercan et al. [69] se fl ati -electr e and they stated that nonthermal
plasma-treated fluids retain their antimicrobial effects for longer periods (three months by delay time
and two years by soluti n agi g) than was earlier thought. This fluid-mediate plasma-based treatment
is faster than reported previously (<15 min holding time, defined as the time that plasma-treated liquid
comes in contact with the bacterial suspension) and inactivates a wide ra ge of multidrug-resistant
bacteria and fung l pathogens, in both their planktonic and biofilm forms. The antimicrobial effect
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is due not only to a change in pH and in the H2O2 or nitric acid but also to the likely generation of
additional species or products that are responsible for the powerful biocidal effect [69].
4. Conclusions
Under the conditions of the present work, A. baumannii may efficiently be deactivated by
atmospheric-pressure cold plasma produced in the form of “guided streamers” which propagate
within helium channeling into atmospheric air. The reported results demonstrated that the application
of this plasma-based method could contribute to restriction of hospital-associated infections and
antibiotic use. Specifically: (i) inhibition zone experiments in agar mirrored the potential action of
the present system against A. baumannii in its planktonic or biofilm mode of growth (e.g., catheter
surface sterilization), whereas (ii) colony count results from the treatment of A. baumannii suspensions
implied the possibility of activating aqueous solutions and their latter use for curing infected areas.
In the first 24 h after a 20 min treatment, the formation of A. baumannii colonies was interrupted
completely and the bacteria were morphologically deformed. A. baumannii eradication did not involve
high temperature phases and should principally be triggered by the plasma-induced reactive species.
Finally, the direct application (physical contact) of the tested plasma jet on patients cannot be justified
by the presently available data, in terms of safety.
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